Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Federal Trade Commission
Accenture
Farmers Insurance
Covington
Express Scripts
Baxter
McKesson

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021271

« Back to Dashboard

NDA 021271 describes IPRIVASK, which is a drug marketed by Valeant Pharms North and is included in one NDA. It is available from one supplier. Additional details are available on the IPRIVASK profile page.

The generic ingredient in IPRIVASK is desirudin recombinant. One supplier is listed for this compound. Additional details are available on the desirudin recombinant profile page.
Summary for 021271
Tradename:IPRIVASK
Applicant:Valeant Pharms North
Ingredient:desirudin recombinant
Patents:0
Suppliers and Packaging for NDA: 021271
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271 NDA Valeant Pharmaceuticals North America LLC 0187-0011 N 0187-0011-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength15MG/VIAL
Approval Date:Apr 4, 2003TE:RLD:Yes

Expired US Patents for NDA 021271

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Sign Up ➤ Sign Up
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Sign Up ➤ Sign Up
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Sign Up ➤ Sign Up
Valeant Pharms North IPRIVASK desirudin recombinant INJECTABLE;SUBCUTANEOUS 021271-001 Apr 4, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Boehringer Ingelheim
Argus Health
Chinese Patent Office
Merck
Fuji
US Army
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.